STRX-210

N/A

Report date: 2024/11/08 10:19:02

Base Information

Drug NameSTRX-210
Drug Alias NameSTRX-210
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionNPC Intracellular Cholesterol Transporter 1 stimulants
TargetsNPC Intracellular Cholesterol Transporter 1
Therapy Area/IndicationsNiemann-Pick Disease, Type C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesStridebio Inc
China Registration ClassN/A

Develop Information

Active CompaniesSarepta Therapeutics IncStridebio Inc
Inactive CompaniesN/A
Active IndicationsNiemann-Pick Disease, Type C
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A